Exxon Mobil Analyst Ratings
Truist Adjusts Price Target on Exxon Mobil to $121 From $124
New Buy Rating for Broadcom (AVGO), the Technology Giant
Guggenheim Adjusts Johnson & Johnson's Price Target to $156 From $160, Maintains Neutral Rating
Raymond James Adjusts Price Target on Procter & Gamble to $187 From $178, Maintains Outperform Rating
Merck & Co. Poised for Growth: Strong Q2 Performance and Promising Pipeline Fuel Buy Rating
Buy Rating Affirmed for Johnson & Johnson on Strong Growth and Strategic Acquisitions
Procter & Gamble Analyst Ratings
Johnson & Johnson Analyst Ratings
AbbVie Analyst Ratings
BMO Capital Adjusts Price Target on Merck to $150 From $148
HSBC Adjusts Price Target on Johnson & Johnson to $174 From $170, Maintains Buy Rating
Barclays Remains a Buy on Procter & Gamble (PG)
RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target
Bank of America Analyst Ratings
Evercore ISI Sticks to Its Buy Rating for Procter & Gamble (PG)
Evercore ISI Adjusts Price Target on Procter & Gamble to $183 From $177, Maintains Outperform Rating
Oppenheimer Adjusts Price Target on Bank of America to $49 From $46, Maintains Outperform Rating
Johnson & Johnson (JNJ) Gets a Buy From RBC Capital
Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $167, Maintains Equalweight Rating